New injection offers hope for Tough-to-Treat skin cancer
NCT ID NCT07227870
Summary
This study is testing whether injecting two experimental drugs directly into tumors can help control advanced basal cell carcinoma, a type of skin cancer. It's for patients whose cancer has continued to grow despite standard treatments or who cannot tolerate those treatments. Participants will receive weekly injections into their tumors for up to four weeks, with the possibility of a second course if they respond well.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED BASAL CELL CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc.
Tampa, Florida, 33612, United States
Contact
-
The University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
Contact
-
Winship Cancer Institute, Emory University
Atlanta, Georgia, 30322, United States
Contact
Conditions
Explore the condition pages connected to this study.